secwatch.observer — SEC 8-K summary
======================================

Issuer:     Prelude Therapeutics Inc (PRLD)
CIK:        0001678660
Form:       8-K
Filed at:   2025-03-28T23:59:59+00:00
Accession:  0000950170-25-046839
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Prelude Therapeutics receives Nasdaq bid price deficiency notice; has until Sep 23, 2025 to cure
--------------------------------------------------------------------------------

- Nasdaq notified Prelude on March 27, 2025 that its common stock closed below $1.00 for 30 consecutive business days.
- Company has 180 calendar days, until September 23, 2025, to regain compliance by closing at $1.00 for 10 consecutive days.
- If not compliant by Sep 23, Prelude may qualify for a second 180-day period if it meets other standards and intends a reverse stock split.
- No immediate impact on listing; stock continues trading on Nasdaq under symbol PRLD.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1678660/000095017025046839/0000950170-25-046839-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1678660/000095017025046839/prld-20250327.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-046839

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer